296 related articles for article (PubMed ID: 8584030)
21. Characterization of the thyroid hormone response element in the skeletal alpha-actin gene: negative regulation of T3 receptor binding by the retinoid X receptor.
Muscat GE; Griggs R; Downes M; Emery J
Cell Growth Differ; 1993 Apr; 4(4):269-79. PubMed ID: 8388243
[TBL] [Abstract][Full Text] [Related]
22. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.
Schroeder C; Gibson L; Zenke M; Beug H
Oncogene; 1992 Feb; 7(2):217-27. PubMed ID: 1347914
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
[TBL] [Abstract][Full Text] [Related]
24. Nucleocytoplasmic shuttling of the thyroid hormone receptor alpha.
Bunn CF; Neidig JA; Freidinger KE; Stankiewicz TA; Weaver BS; McGrew J; Allison LA
Mol Endocrinol; 2001 Apr; 15(4):512-33. PubMed ID: 11266504
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional regulation of human thyroid hormone receptor beta 1 gene expression: effect of human retinoid X receptor and identification of a transcriptional silencer region.
Sakurai A; Suzuki S; Katai M; Miyamoto T; Kobayashi H; Nakajima K; Ichikawa K; DeGroot LJ; Hashizume K
Mol Cell Endocrinol; 1995 Apr; 110(1-2):103-12. PubMed ID: 7672440
[TBL] [Abstract][Full Text] [Related]
26. 3,5,3'-triiodothyronine (T3) receptor-auxiliary protein (TRAP) binds DNA and forms heterodimers with the T3 receptor.
Darling DS; Beebe JS; Burnside J; Winslow ER; Chin WW
Mol Endocrinol; 1991 Jan; 5(1):73-84. PubMed ID: 1850111
[TBL] [Abstract][Full Text] [Related]
27. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone.
Takeda T; Suzuki S; Liu RT; DeGroot LJ
J Clin Endocrinol Metab; 1995 Jul; 80(7):2033-40. PubMed ID: 7608251
[TBL] [Abstract][Full Text] [Related]
28. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific.
Zavacki AM; Harney JW; Brent GA; Larsen PR
Mol Endocrinol; 1993 Oct; 7(10):1319-30. PubMed ID: 8264663
[TBL] [Abstract][Full Text] [Related]
29. Thyroid hormone receptor/c-erbA: control of commitment and differentiation in the neuronal/chromaffin progenitor line PC12.
Muñoz A; Wrighton C; Seliger B; Bernal J; Beug H
J Cell Biol; 1993 Apr; 121(2):423-38. PubMed ID: 8385673
[TBL] [Abstract][Full Text] [Related]
30. Repression of glucocorticoid receptor-mediated transcriptional activation by unliganded thyroid hormone receptor (TR) is TR isoform-specific.
Spanjaard RA; Nguyen VP; Chin WW
Endocrinology; 1995 Nov; 136(11):5084-92. PubMed ID: 7588245
[TBL] [Abstract][Full Text] [Related]
31. Difference in dominant negative activities between mutant thyroid hormone receptors alpha1 and beta1 with an identical truncation in the extreme carboxyl-terminal tau4 domain.
Nishiyama K; Andoh S; Kitahara A; Natsume H; Mikami T; Genma R; Nakamura H
Mol Cell Endocrinol; 1998 Mar; 138(1-2):95-104. PubMed ID: 9685218
[TBL] [Abstract][Full Text] [Related]
32. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).
Saatcioglu F; Bartunek P; Deng T; Zenke M; Karin M
Mol Cell Biol; 1993 Jun; 13(6):3675-85. PubMed ID: 8098843
[TBL] [Abstract][Full Text] [Related]
33. Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors.
Wong R; Zhu XG; Pineda MA; Cheng SY; Weintraub BD
Mol Med; 1995 Mar; 1(3):306-19. PubMed ID: 8529109
[TBL] [Abstract][Full Text] [Related]
34. Factors influencing nuclear receptors in transcriptional repression.
Burcin M; Köhne AC; Runge D; Steiner C; Renkawitz R
Semin Cancer Biol; 1994 Oct; 5(5):337-46. PubMed ID: 7849262
[TBL] [Abstract][Full Text] [Related]
35. The herpes simplex virus thymidine kinase gene promoter contains a novel thyroid hormone response element.
Park HY; Davidson D; Raaka BM; Samuels HH
Mol Endocrinol; 1993 Mar; 7(3):319-30. PubMed ID: 8387156
[TBL] [Abstract][Full Text] [Related]
36. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone.
Safer JD; Langlois MF; Cohen R; Monden T; John-Hope D; Madura J; Hollenberg AN; Wondisford FE
Mol Endocrinol; 1997 Jan; 11(1):16-26. PubMed ID: 8994184
[TBL] [Abstract][Full Text] [Related]
37. Activation of myoD gene transcription by 3,5,3'-triiodo-L-thyronine: a direct role for the thyroid hormone and retinoid X receptors.
Muscat GE; Mynett-Johnson L; Dowhan D; Downes M; Griggs R
Nucleic Acids Res; 1994 Feb; 22(4):583-91. PubMed ID: 8127707
[TBL] [Abstract][Full Text] [Related]
38. Identification of DNA binding sites for the V-erbA oncoprotein, the viral homolog to thyroid hormone receptor alpha.
Harbers M; Wahlström GM; Vennström B
J Steroid Biochem Mol Biol; 1998 Nov; 67(3):181-91. PubMed ID: 9879977
[TBL] [Abstract][Full Text] [Related]
39. Human carboxyl-terminal variant of alpha-type c-erbA inhibits trans-activation by thyroid hormone receptors without binding thyroid hormone.
Lazar MA; Hodin RA; Chin WW
Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7771-4. PubMed ID: 2554288
[TBL] [Abstract][Full Text] [Related]
40. L-thyroxine directly affects expression of thyroid hormone-sensitive genes: regulatory effect of RXRbeta.
Bogazzi F; Bartalena L; Brogioni S; Burelli A; Grasso L; Dell'Unto E; Manetti L; Martino E
Mol Cell Endocrinol; 1997 Oct; 134(1):23-31. PubMed ID: 9406846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
